VIEW PRESS RELEASE [PDF] 05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The…
Blog Archives
PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess…
Tagged with: brady kinesia, company, dbs, deep brain stimulation, development, funding, growth, homeview, parkinson's disease, pd, pharmaceutical, stroke, symptom response, telemedicine, therapy, treatment, tremor, updrs
PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education
VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of…
Tagged with: balance, biomedical engineering, bme, company, data analysis, dbs, dcs, deep brain stimulation, development, direct current stimulation, education, funding, gait, growth, learning, motion sensor, neurotechnology, nih, parkinson's disease, physiological monitor, ridigity, sbir, signal acquisition, teaching, telemedicine, tremor, wireless physiology
PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders
VIEW PRESS RELEASE [PDF] 01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential…
Tagged with: baylor college of medicine, essential tremor, et, funding, kinesia, nih, parkinson's disease, rush university medical center, sbir, tremor
PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment…
Tagged with: bradykinesia, cleveland clinic foundation, dbs, deep brain stimulation, efficacy, funding, kinesia, nih, parkinson's disease, pd, rigidity, tremor, updrs
Press Release: CLEVEMED AWARDED $896,000 NIH GRANT TO HELP STROKE PATIENTS RECOVER LOST MOTOR FUNCTION
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, October 24, 2006 – Cleveland Medical Devices Inc. (CleveMed) has been awarded a $896,000 Phase II grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)…